What the election could mean for hot healthcare startups
Welcome to Business Insider‘s daily healthcare newsletter, your daily dose of pharma, biotech, and
Today’s a big earnings day for some of the major drugmakers in the COVID-19 vaccine and treatment race including Pfizer, Merck, and Eli Lilly. (No, we don’t yet have data on Pfizer’s late-stage COVID-19 vaccine trial.)
Meanwhile late on Monday, the Senate confirmed Amy Coney Barrett to the Supreme Court. Kimberly Leonard has the story on what adding a conservative judge could mean for Roe v. Wade, and the 16 abortion case that are making their way up to the high court right now.
Also today: We asked 14 top digital health leaders what the election will mean for the industry, 6 mental health startups that raised the most cash in the third quarter, and potentially diverging approval standards between Europe and the US.
5 ways the election could upend digital health, according to 14 healthcare CEOs, investors, and policy experts
Here are the 6 mental health startups raising the most cash as the pandemic overwhelms workers and companies
The EU’s drug regulator would reportedly approve a COVID-19 vaccine even if it worked in less than 50% of people — a lower threshold than the FDA
More stories we’re reading: